{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T16:21:55Z","timestamp":1719937315736},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ypmed.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T11:12:12Z","timestamp":1508757132000},"page":"378-380","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions"],"prefix":"10.1016","volume":"105","author":[{"given":"Mark","family":"Schiffman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ypmed.2017.09.010_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ypmed.2017.09.010_bb0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ijc.30781","article-title":"Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer","volume":"141","author":"Clarke","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ypmed.2017.09.010_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ypmed.2017.09.010_bb0020","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ypmed.2017.09.010_bb0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"5 Suppl 1","key":"10.1016\/j.ypmed.2017.09.010_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2017.09.010_bb0035","article-title":"Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: a literature review","author":"Maver","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ypmed.2017.09.010_bb0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Force USPST. Screening for cervical cancer: U.S. preventive services task force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"9916","key":"10.1016\/j.ypmed.2017.09.010_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ypmed.2017.09.010_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"9590","key":"10.1016\/j.ypmed.2017.09.010_bb0055","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2017.09.010_bb0060","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.ypmed.2017.09.010_bb0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ijc.30456","article-title":"Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have \u2265CIN2","volume":"140","author":"Schiffman","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ypmed.2017.09.010_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000300","article-title":"Preparing for the next round of ASCCP-sponsored cervical screening and management guidelines","volume":"21","author":"Schiffman","year":"2017","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"23","key":"10.1016\/j.ypmed.2017.09.010_bb0075","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/cncr.30277","article-title":"The population impact of human papillomavirus\/cytology cervical cotesting at 3-year intervals: reduced cervical cancer risk and decreased yield of precancer per screen","volume":"122","author":"Silver","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2017.09.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30901","article-title":"Cervical cancer in Africa, Latin America and the Caribbean and Asia: regional inequalities and changing trends","author":"Vaccarella","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"22","key":"10.1016\/j.ypmed.2017.09.010_bb0085","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jnci\/djs425","article-title":"Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3","volume":"104","author":"Wentzensen","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.ypmed.2017.09.010_bb0090","doi-asserted-by":"crossref","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ypmed.2017.09.010_bb0095","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/ijc.30579","article-title":"Eurogin 2016 roadmap: how HPV knowledge is changing screening practice","volume":"140","author":"Wentzensen","year":"2017","journal-title":"Int. J. Cancer"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351730333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351730333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T18:10:30Z","timestamp":1537812630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174351730333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":19,"alternative-id":["S009174351730333X"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.09.010","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}